Caladrius Biosciences to Present at the BIO Investor Forum Digital
BASKING RIDGE, N.J., Oct. 06, 2020 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage […]
Oaktree Strategic Income Corporation Schedules Fourth Fiscal Quarter and Full Year 2020 Earnings Conference Call for November 19, 2020
12:30 p.m. Eastern Time / 9:30 a.m. Pacific TimeLOS ANGELES, CA, Oct. 06, 2020 (GLOBE NEWSWIRE) — Oaktree Strategic Income […]
SeaSpine Research to Feature at Multiple NASS Podium Presentations
CARLSBAD, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on […]
Arcutis Biotherapeutics Announces Closing of Public Offering and Concurrent Private Placement of Common Stock
WESTLAKE VILLAGE, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on […]
Midland States Bancorp, Inc. to Announce Third Quarter 2020 Financial Results on Thursday, October 22
EFFINGHAM, Ill., Oct. 06, 2020 (GLOBE NEWSWIRE) — Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that it will issue […]
Oaktree Specialty Lending Corporation Schedules Fourth Fiscal Quarter and Full Year 2020 Earnings Conference Call for November 19, 2020
11:00 a.m. Eastern Time / 8:00 a.m. Pacific TimeLOS ANGELES, CA, Oct. 06, 2020 (GLOBE NEWSWIRE) — Oaktree Specialty Lending […]
Synchronoss Technologies Engages MKR Investor Relations, Inc.
BRIDGEWATER, N.J., Oct. 06, 2020 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (NASDAQ: SNCR), a global leader and innovator in cloud, […]
Processa Pharmaceuticals Closes $19.2 Million Public Offering
HANOVER, MD, Oct. 06, 2020 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage biopharmaceutical company focused on the […]
C4 Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
WATERTOWN, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a biopharmaceutical company pioneering a new […]
Landec Corporation Reports First Quarter Fiscal Year 2021 Results
SANTA MARIA, Calif., Oct. 06, 2020 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with […]
